『Endocrine Management in the SICU』のカバーアート

Endocrine Management in the SICU

Endocrine Management in the SICU

無料で聴く

ポッドキャストの詳細を見る

概要

 This text outlines the management of endocrine disorders within surgical intensive care settings, focusing on how critical illness or trauma disrupts the body’s hormonal balance. It details specific conditions involving the hypothalamus, pituitary, and adrenal glands, including salt and water imbalances like diabetes insipidus and SIADH. The authors examine the complexities of thyroid dysfunction and adrenal insufficiency, highlighting the ongoing medical debates regarding steroid and insulin therapies. Additionally, the source addresses the challenges of glycemic control and the utility of procalcitonin as a biomarker for infection. Ultimately, the text emphasizes that early clinical recognition and aggressive intervention are vital to reducing mortality in patients with these metabolic derangements. The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns. Management of Endocrine Disorders in the Surgical Intensive Care Unit The endocrine system serves as a sophisticated communication network between the nervous system and end organs, primarily through the neuroendocrine axis. This axis, comprising the hypothalamus, pituitary, and various peripheral glands, is essential for maintaining homeostasis during critical illness. In the Surgical Intensive Care Unit (SICU), patients may experience physiologic alterations in endocrine function due to acute stress or have underlying disorders that complicate their recovery. The Neuroendocrine Axis and Stress Response The neuroendocrine axis is activated by physiologic signals, trauma, or stress. This activation triggers the release of hormones—messengers such as peptides or steroids—that bind to receptors to initiate metabolic and immune responses. Endocrinopathies are classified based on the site of dysfunction: Primary: Dysfunction of the peripheral endocrine gland.Secondary: Dysfunction of the pituitary gland.Tertiary: Dysfunction of the hypothalamus. Brain injuries, including traumatic brain injury (TBI), mass lesions, or hypoxic injuries, can disrupt the regulation of hormones originating in the hypothalamus or pituitary. Cerebral edema or increased intracranial pressure often restricts blood flow to these areas, leading to significant abnormalities in sodium and water balance. Disorders of Sodium and Water Balance Distinguishing between the various causes of sodium and water abnormalities is critical for effective management in the SICU. Diabetes Insipidus (DI) Diabetes insipidus results from either a lack of arginine vasopressin (ADH), known as Central DI, or a lack of renal response to the hormone, known as Nephrogenic DI. Pathophysiology: Central DI is characterized by polyuria and water diuresis. In neurosurgical patients, diagnosis is often suspected when urine output exceeds 200 mL/hr for two consecutive hours.Clinical Presentation: Patients exhibit hypernatremia (serum sodium >145 mEq/L), serum osmolality >290 mOsm/kg, and dilute urine (osmolality <300 mOsm/kg; specific gravity <1.005 g/mL).Treatment: Primary interventions include fluid replacement and vasopressin. DDAVP (1-deamino-8-D-arginine vasopressin) is typically administered at 2 to 4 μg IV or 10 to 60 μg intranasally. Water deficits must be replaced slowly—typically only half the deficit in the first 24 hours—to prevent demyelination. SIADH vs. Cerebral Salt Wasting (CSW) Both conditions present with hyponatremia and hypotonicity, but they require opposing treatments based on the patient's volume status. SIADH (Syndrome of Inappropriate Antidiuretic Hormone): Caused by excessive ADH release leading to water retention. Patients are typically euvolemic. Treatment focuses on fluid restriction (800–1000 mL/day). Normal saline is discouraged as it may worsen hyponatremia if fluids administered do not exceed urine osmolality.Cerebral Salt Wasting (CSW): Resulting from a natriuretic peptide that causes sodium and volume depletion. Patients are hypovolemic (exhibiting tachycardia, low CVP, or orthostatic hypotension). Treatment requires volume expansion with normal saline.Differentiation: While both show low serum sodium and high urine sodium (>20–40 mEq/L), SIADH patients have normal volume status, whereas CSW patients are volume-depleted. Fractional excretion of urate (FEurate) can also help; it normalizes in SIADH after hyponatremia correction but remains abnormal in CSW. Abnormalities in Thyroid Response Thyroid hormones are essential for cellular metabolism. Critical illness can impact thyroid function through central (TRH/TSH) or peripheral (T4 to T3 conversion) mechanisms. Thyroid Storm Thyroid storm is a severe, life-threatening form of ...
まだレビューはありません